LA
TMO icon

Lifeworks Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Lifeworks Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-393
Closed -$228K – 344
2025
Q4 		$228K Buy
+393
New +$222K 0.03% 301
2025
Q2 		– Sell
-452
Closed -$225K – 330
2025
Q1 		$225K Buy
+452
New +$245K 0.04% 282
2024
Q4 		– Sell
-364
Closed -$225K – 321
2024
Q3 		$225K Buy
+364
New +$215K 0.04% 276
2024
Q2 		– Sell
-359
Closed -$209K – 245
2024
Q1 		$209K Sell
359
-113
-24% -$63.4K 0.06% 221
2023
Q4 		$251K Buy
472
+9
+2% +$4.36K 0.09% 178
2023
Q3 		$234K Sell
463
-7
-1% -$3.73K 0.09% 168
2023
Q2 		$245K Sell
470
-31
-6% -$16.7K 0.1% 141
2023
Q1 		$289K Sell
501
-227
-31% -$128K 0.14% 122
2022
Q4 		$401K Sell
728
-245
-25% -$130K 0.23% 91
2022
Q3 		$500K Sell
973
-194
-17% -$109K 0.28% 90
2022
Q2 		$634K Buy
1,167
+445
+62% +$245K 0.4% 82
2022
Q1 		$426K Buy
722
+125
+21% +$71.8K 0.28% 89
2021
Q4 		$398K Buy
+597
New +$373K 0.32% 87

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lifeworks Advisors's TMO Position: Q1 2026 in Review

Lifeworks Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 393 shares — an estimated $228K sold.

Lifeworks Advisors first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $634K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Lifeworks Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Lifeworks Advisors sold 393 Thermo Fisher Scientific shares in Q1 2026, an estimated $228K.
  • Lifeworks Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
  • Lifeworks Advisors's Thermo Fisher Scientific position peaked at $634K in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.